MedPath

The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection

Phase 4
Completed
Conditions
Surgical Site Infection
Registration Number
NCT01019447
Lead Sponsor
Cairo University
Brief Summary

To compare conventional polyglactin 910 sutures with triclosan-coated polyglactin 910 antimicrobial sutures for the reduction of surgical site infections and any associated health and economic benefits.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
701
Inclusion Criteria
  • All patients of different age
  • Gender
  • Risk factors and procedures candidate for surgical intervention during the period of the study
Exclusion Criteria
  • Patients with an established pre-operative infection at the operative site

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Signs of Surgical Site Infections (SSI) according to Centers for Disease Control (CDC) criteria30 days (or 1 year in case of prosthesis)
Secondary Outcome Measures
NameTimeMethod
Post-operative hospital stay in days30 days

Trial Locations

Locations (2)

Al-Zeraaein Hospital

🇪🇬

Cairo, Egypt

Cairo University Kasr Al-Aini Hospital

🇪🇬

Cairo, Egypt

Al-Zeraaein Hospital
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.